Piscuoglio, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 4.546
AS - Asia 3.667
SA - Sud America 717
EU - Europa 645
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 77
OC - Oceania 6
Totale 9.846
Nazione #
US - Stati Uniti d'America 4.373
SG - Singapore 2.192
CN - Cina 661
BR - Brasile 568
VN - Vietnam 343
IT - Italia 261
HK - Hong Kong 172
CA - Canada 74
GB - Regno Unito 71
DE - Germania 57
IN - India 55
AR - Argentina 49
MX - Messico 49
BD - Bangladesh 41
RU - Federazione Russa 37
FR - Francia 36
FI - Finlandia 35
EC - Ecuador 29
IQ - Iraq 27
VE - Venezuela 22
PL - Polonia 21
NL - Olanda 18
TR - Turchia 18
MY - Malesia 16
UZ - Uzbekistan 16
ZA - Sudafrica 16
ID - Indonesia 15
CO - Colombia 14
PK - Pakistan 14
ES - Italia 13
JP - Giappone 13
KE - Kenya 13
SA - Arabia Saudita 13
NG - Nigeria 12
SE - Svezia 12
CL - Cile 11
CR - Costa Rica 11
IE - Irlanda 11
MA - Marocco 11
PY - Paraguay 11
UA - Ucraina 11
PH - Filippine 9
HN - Honduras 8
KG - Kirghizistan 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
JO - Giordania 6
NP - Nepal 6
AL - Albania 5
AT - Austria 5
AU - Australia 5
AZ - Azerbaigian 5
EG - Egitto 5
LT - Lituania 5
AM - Armenia 4
BE - Belgio 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
GT - Guatemala 4
IL - Israele 4
LB - Libano 4
NI - Nicaragua 4
RO - Romania 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BG - Bulgaria 3
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
IR - Iran 3
LU - Lussemburgo 3
LV - Lettonia 3
PR - Porto Rico 3
RS - Serbia 3
TN - Tunisia 3
TW - Taiwan 3
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
GA - Gabon 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
MG - Madagascar 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
Totale 9.644
Città #
Singapore 855
San Jose 729
Ashburn 533
The Dalles 325
Shanghai 225
Beijing 216
Council Bluffs 195
New York 193
Dallas 192
Hong Kong 165
Santa Clara 144
Ho Chi Minh City 122
Los Angeles 115
Milan 97
Hanoi 80
Wilmington 59
Buffalo 53
Chandler 53
São Paulo 52
Boardman 44
Phoenix 40
Helsinki 33
San Mateo 32
Chicago 31
Brooklyn 25
Rome 24
Mexico City 23
North Bergen 21
Seattle 21
Atlanta 20
Haiphong 19
Orem 19
Naples 18
Princeton 18
Warsaw 17
Boston 16
Da Nang 16
Tashkent 16
Toronto 15
Belo Horizonte 14
Chennai 14
Frankfurt am Main 14
Houston 14
Montreal 13
Munich 13
Rio de Janeiro 13
Tokyo 13
Denver 12
Lawrence 12
Paris 12
San Francisco 12
Dublin 11
Johannesburg 11
Abbeville 10
Benin City 10
Brasília 10
Dhaka 10
Fairfield 10
Figino 10
London 10
Manchester 10
Moscow 10
Nairobi 10
Queens 10
Biên Hòa 9
Guayaquil 9
Kuala Lumpur 9
Miami 9
San José 9
Abbiategrasso 8
Ankara 8
Assago 8
Baghdad 8
Campinas 8
Charlotte 8
Columbus 8
Goiânia 8
Mumbai 8
Philadelphia 8
Amsterdam 7
Bishkek 7
Buenos Aires 7
Cleveland 7
Curitiba 7
Fortaleza 7
Guarulhos 7
Kingston 7
Las Vegas 7
Quito 7
San Diego 7
Stockholm 7
Cao Lanh 6
Fresno 6
Hải Dương 6
Indianapolis 6
Jackson 6
Katy 6
Lahore 6
Milwaukee 6
Pasadena 6
Totale 5.422
Nome #
SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules 201
PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition 114
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies. 101
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 101
PS-24-008 Prevalence of vessels encapsulating tumour clusters (VETC) in human cancers 98
Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients 93
HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma 93
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies 91
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis 83
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: A proof-of-principle 82
Arginine reprograms metabolism in liver cancer via RBM39 82
In vivo interaction screening reveals liver-derived constraints to metastasis 82
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 80
Skeletal Muscle Disorders: A Non-cardiac Source of Cardiac Troponin T 80
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer 80
Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma 79
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations 78
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal can-cer. 78
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer 78
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 77
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients 75
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations 75
The Genomic Landscape of Male Breast Cancers 73
The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective 72
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer 71
Alterations in Homologous Recombination Repair Genes in Prostate Cancer Brain Metastases 71
Genetic profiling using plasma-derived cell-free DNA in therapy-naive hepatocellular carcinoma patients: A pilot study 71
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer 70
Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular Carcinoma 70
Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology 69
Breast cancer intra-tumor heterogeneity 69
Genomic landscape of adenoid cystic carcinoma of the breast 69
The protein histidine phosphatase LHPP is a tumour suppressor 69
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer 68
Genomic characterization of metastatic breast cancers 67
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast 67
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases 67
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis 66
Variant Calling Methods and Protocols 66
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma 65
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues 65
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas 64
Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids 64
A Hepatocellular Cancer Patient-derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth 64
Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue 63
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook 63
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer 62
Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients 62
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors 62
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas 62
A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors 61
The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas 61
3 '-UTR Poly(T/U) Tract Deletions and Altered Expression of EWSR1 Are a Hallmark of Mismatch Repair-Deficient Cancers 61
Colitis Is Associated with Loss of the Histidine Phosphatase LHPP and Upregulation of Histidine Phosphorylation in Intestinal Epithelial Cells 60
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members 60
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle (vol 25, pg 1729, 2014) 60
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysis 60
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor 60
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas 60
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes 60
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens 60
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 59
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 59
A Pygopus 2-Histone Interaction Is Critical for Cancer Cell Dedifferentiation and Progression in Malignant Breast Cancer 58
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma 58
Minor intron splicing is critical for survival of lethal prostate cancer 58
Patient-derived xenografts and organoids model therapy response in prostate cancer 58
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer 58
The Role of Long Non-Coding RNAs in Hepatocarcinogenesis 57
Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer 57
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity 57
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages 57
Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways 57
Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening 57
PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data 57
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 56
Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing 56
Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer 56
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support 56
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer 56
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy 56
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 56
mTOR signaling mediates ILC3-driven immunopathology 56
Contralateral breast cancers: Independent cancers or metastases? 55
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships 55
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic Therapy 55
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing 54
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models 54
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas 53
Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer 53
Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology 53
Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma 53
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations 53
ZNRF3 and RNF43 cooperate to safeguard metabolic liver zonation and hepatocyte proliferation 52
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer 52
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 52
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma 52
The Genomic Landscape of Mucinous Breast Cancer 52
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 52
miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase–Protein Kinase B Pathway in Chronically Inflamed Liver 52
Totale 6.692
Categoria #
all - tutte 55.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202254 0 0 0 16 0 0 1 12 2 1 12 10
2022/2023146 26 10 26 10 11 9 1 15 19 16 3 0
2023/2024671 1 12 16 4 5 215 31 38 30 39 111 169
2024/20251.899 33 8 9 41 16 249 108 104 323 469 273 266
2025/20265.139 713 430 219 490 116 255 1.380 270 204 390 343 329
2026/20271.836 261 336 855 384 0 0 0 0 0 0 0 0
Totale 9.846